Headache Relief

NDC 83324-331 · Chain Drug Marketing Association, Inc.

Generic nameAcetaminophen, Aspirin, Caffeine

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)ACETAMINOPHEN, ASPIRIN, CAFFEINE

Strength250; 250; 65 mg/1; mg/1; mg/1

Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]

Marketing categoryOTC MONOGRAPH DRUG

Packages

83324-331-01 — 1 BOTTLE, PLASTIC in 1 CARTON (83324-331-01) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

83324-331-24 — 1 BOTTLE, PLASTIC in 1 CARTON (83324-331-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

83324-164 — Acetaminophen Dextromethorphan HBr Doxylamine Succinate, 83324-166 — Acetaminophen Diphenhydramine HCl, 83324-167 — Acetaminophen Dextromethorphan HBr Phenylephrine HCl, 83324-168 — Acetaminophen Dextromethorphan HBr Phenylephrine HCl, 83324-178 — Acetaminophen and Ibuprofen, 83324-205 — ASPIRIN, 83324-224 — Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride, 83324-239 — Aspirin, Chlorpheniramine maleate, Phenylephrine bitartrate, 83324-240 — Aspirin, Chlorpheniramine maleate, Phenylephrine bitartrate, 83324-241 — Aspirin, Anhydrous citric acid, Sodium bicarbonate, 83393-390 — Acetaminophen, Caffeine, Pyrilamine maleate, 83474-001 — ACETAMINOPHEN, 83586-004 — Acetaminophen, Diphenhydramine Hydrochloride, and Phenylephrine Hydrochloride, 83586-104 — Aspirin, 83586-107 — Acetaminophen, 83586-115 — Aspirin, 83720-500 — Acetaminophen, 83934-673 — Acetaminophen, 83939-0010 — Acetaminophen, 83939-0011 — Acetaminophen, +4118 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.